We are live on ! Find out more
AC

Ayrton Capital Portfolio holdings

AUM $14.7M
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-4.84%
1 Year Est. Return
-12.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57M
AUM Growth
-$4.55M
Cap. Flow
-$5.82M
Cap. Flow %
-10.22%
Top 10 Hldgs %
51.56%
Holding
131
New
10
Increased
1
Reduced
4
Closed
12

Top Buys

Rank Stock Value
1
PMCB icon
PharmaCyte Biotech
PMCB
+$2.23M
2
PAVM icon
PAVmed
PAVM
+$2.01M
3
SLAI
SOLAI Ltd ADS
SLAI
+$191K
4
AYTU icon
AYTU BioPharma
AYTU
+$172K
5
LUCYW icon
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
+$98.9K

Top Sells

Rank Stock Value
1
MMV
MultiMetaVerse Holdings Limited Class A Ordinary Share
MMV
+$1.78M
2
RICO
Agrico Acquisition Corp
RICO
+$668K
3
WARR
Warrior Technologies Acquisition Company
WARR
+$654K
4
GGGV
G3 VRM Acquisition Corp. Class A Common Stock
GGGV
+$347K
5
MOBX icon
Mobix Labs
MOBX
+$126K

Sector Composition

Rank Sector Weight
1 Financials 49.52%
2 Healthcare 19.11%
3 Technology 6.46%
4 Consumer Discretionary 4.18%
5 Communication Services 3.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSAC
26
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$739K 1.3%
74,600
– –
BSGA
27
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
$719K 1.26%
70,000
– –
MEOA
28
DELISTED
Minority Equality Opportunities Acquisition Inc. Class A Common Stock
MEOA
$710K 1.25%
70,000
– –
BRLS icon
29
Borealis Foods
BRLS
$16.7M
$607K 1.06%
60,000
– –
SOC icon
30
Sable Offshore Corp
SOC
$1.01B
$550K 0.96%
55,929
– –
GCTS
31
GCT Semiconductor Holding
GCTS
$169M
$502K 0.88%
50,000
– –
RCHG
32
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
$425K 0.75%
42,000
– –
EUDA icon
33
EUDA Health Holdings
EUDA
$57.8M
$401K 0.7%
2,000
– –
TWLV
34
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
$392K 0.69%
39,767
– –
POL.WS
35
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$250K 0.44%
2,000,000
– –
BRTX icon
36
BioRestorative Therapies
BRTX
$5.22M
$198K 0.35%
61,418
– –
MTC icon
37
MMTec
MTC
$404M
$131K 0.23%
11,404
-7,049
-38% -$118K
PEPL
38
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$130K 0.23%
13,028
– –
SLAI
39
DELISTED
SOLAI Ltd ADS
SLAI
$102K 0.18%
+5,184
New +$191K
AYTU icon
40
AYTU BioPharma
AYTU
$23.9M
$84K 0.15%
+22,611
New +$172K
SKYAW
41
SkyAI Inc
SKYAW
$263K
$83K 0.15%
235,200
– –
SURGW
42
DELISTED
SurgePays, Inc. Warrant
SURGW
$63K 0.11%
49,000
-1,000
-2% -$1.53K
LUCYW icon
43
Innovative Eyewear Inc Series A Warrants 8/16/27
LUCYW
$87.4K
$60K 0.11%
+150,000
New +$98.9K
SWAGW icon
44
Stran & Company Warrant
SWAGW
$58K 0.1%
224,260
– –
TRKA
45
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$49K 0.09%
+5,793
New +$93.9K
UNCY icon
46
Unicycive Therapeutics
UNCY
$137M
$45K 0.08%
7,665
– –
NLSPW
47
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$43K 0.08%
170,100
– –
AIMDW icon
48
Ainos Warrants
AIMDW
$38K 0.07%
+50,000
New +$32.2K
GRNAW
49
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$34K 0.06%
150,000
– –
BEATW icon
50
Heartbeam Inc Warrant
BEATW
$29K 0.05%
50,000
– –
1
2
3 4 5

Similar funds

VVA
Vintage Ventures Advisors Herzliya, Israel $15.2M AUM 35.41% 1-Year Est. Return
AR
Acacia Research New York $14.1M AUM 50.98% 1-Year Est. Return
TAM
Toscafund Asset Management London, United Kingdom $15.6M AUM 12.56% 1-Year Est. Return
RCGI
Ribbit Capital GP IV Palo Alto, California $15.6M AUM 103.62% 1-Year Est. Return
AEM
ACON Equity Management Washington, District of Columbia $13.8M AUM 62.17% 1-Year Est. Return
CAM
Connacht Asset Management New York $16.9M AUM 40.41% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return

Ayrton Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Ayrton Capital held 131 positions worth $57M, down 7.4% from $61.6M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Ayrton Capital withdrew a net $5.82M in Q3 2022, closing 12 positions and reducing 4 holdings. Its most notable exit was MultiMetaVerse Holdings Limited Class A Ordinary Share, an estimated $1.78M position sold in full.

By sector, the portfolio is most concentrated in Financials at 50% of assets, down from 54% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Ayrton Capital opened a new position in PAVmed worth $1.38M.

  • Ayrton Capital's largest Q3 2022 buy was PAVmed: 3,555 shares worth $1.38M.
  • Ayrton Capital added most to PharmaCyte Biotech in Q3 2022, an estimated $2.23M increase.
  • Ayrton Capital's biggest Q3 2022 reduction was Mobix Labs, cutting an estimated $126K.
  • Ayrton Capital fully exited MultiMetaVerse Holdings Limited Class A Ordinary Share in Q3 2022, selling an estimated $1.78M.
  • Ayrton Capital's ten largest holdings make up 52% of its $57M portfolio in Q3 2022.
  • Ayrton Capital opened 10 new positions and closed 12 in Q3 2022.
  • Ayrton Capital's portfolio value fell 7.4% quarter-over-quarter to $57M.

Based on Ayrton Capital's 13F filing for Q3 2022, filed 9 Nov 2022.